CEO Joe Lacher highlighted strong financial results for Q4, including net income of $97 million and a 12% return on equity for the year. Specialty auto remained a key driver, with a combined ratio of ...

Chief Investment Officer Kevin Crummy detailed plans for the new Westwood joint venture, estimating a total investment of $150 million to $200 million over three to four years. He added that the JV ...

The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.